These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 30613980)
1. Metabolic factors and the risk of colorectal cancer by KRAS and BRAF mutation status. Myte R; Gylling B; Häggström J; Häggström C; Zingmark C; Löfgren Burström A; Palmqvist R; Van Guelpen B Int J Cancer; 2019 Jul; 145(2):327-337. PubMed ID: 30613980 [TBL] [Abstract][Full Text] [Related]
2. One-carbon metabolism biomarkers and genetic variants in relation to colorectal cancer risk by KRAS and BRAF mutation status. Myte R; Gylling B; Häggström J; Schneede J; Löfgren-Burström A; Huyghe JR; Hallmans G; Meyer K; Johansson I; Ueland PM; Palmqvist R; Van Guelpen B PLoS One; 2018; 13(4):e0196233. PubMed ID: 29694444 [TBL] [Abstract][Full Text] [Related]
3. A longitudinal study of prediagnostic metabolic biomarkers and the risk of molecular subtypes of colorectal cancer. Myte R; Harlid S; Sundkvist A; Gylling B; Häggström J; Zingmark C; Burström AL; Palmqvist R; Guelpen BV Sci Rep; 2020 Mar; 10(1):5336. PubMed ID: 32210264 [TBL] [Abstract][Full Text] [Related]
4. Associations of anthropometric factors with KRAS and BRAF mutation status of primary colorectal cancer in men and women: a cohort study. Brändstedt J; Wangefjord S; Nodin B; Eberhard J; Sundström M; Manjer J; Jirström K PLoS One; 2014; 9(2):e98964. PubMed ID: 24918610 [TBL] [Abstract][Full Text] [Related]
5. BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis. Nam SK; Yun S; Koh J; Kwak Y; Seo AN; Park KU; Kim DW; Kang SB; Kim WH; Lee HS PLoS One; 2016; 11(3):e0151865. PubMed ID: 26991109 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of BRAF and KRAS Mutation in Relation to Colorectal Cancer Survival in Iranian Patients: Correlated to Microsatellite Instability. Nazemalhosseini-Mojarad E; Kishani Farahani R; Mehrizi M; Baghaei K; Yaghoob Taleghani M; Golmohammadi M; Peyravian N; Ashtari S; Pourhoseingholi MA; Asadzadeh Aghdaei H; Zali MR J Gastrointest Cancer; 2020 Mar; 51(1):53-62. PubMed ID: 30635874 [TBL] [Abstract][Full Text] [Related]
7. External validation of molecular subtype classifications of colorectal cancer based on microsatellite instability, CIMP, BRAF and KRAS. Alwers E; Bläker H; Walter V; Jansen L; Kloor M; Arnold A; Sieber-Frank J; Herpel E; Tagscherer KE; Roth W; Chang-Claude J; Brenner H; Hoffmeister M BMC Cancer; 2019 Jul; 19(1):681. PubMed ID: 31296182 [TBL] [Abstract][Full Text] [Related]
8. Dietary Patterns and Risk of Colorectal Cancer: Analysis by Tumor Location and Molecular Subtypes. Mehta RS; Song M; Nishihara R; Drew DA; Wu K; Qian ZR; Fung TT; Hamada T; Masugi Y; da Silva A; Shi Y; Li W; Gu M; Willett WC; Fuchs CS; Giovannucci EL; Ogino S; Chan AT Gastroenterology; 2017 Jun; 152(8):1944-1953.e1. PubMed ID: 28249812 [TBL] [Abstract][Full Text] [Related]
9. Risk Factors and Incidence of Colorectal Cancer According to Major Molecular Subtypes. Wang L; He X; Ugai T; Haruki K; Lo CH; Hang D; Akimoto N; Fujiyoshi K; Wang M; Fuchs CS; Meyerhardt JA; Zhang X; Wu K; Chan AT; Giovannucci EL; Ogino S; Song M JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33442661 [TBL] [Abstract][Full Text] [Related]
10. Association of Aspirin and Nonsteroidal Anti-Inflammatory Drugs With Colorectal Cancer Risk by Molecular Subtypes. Amitay EL; Carr PR; Jansen L; Walter V; Roth W; Herpel E; Kloor M; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M J Natl Cancer Inst; 2019 May; 111(5):475-483. PubMed ID: 30388256 [TBL] [Abstract][Full Text] [Related]
11. Relationships among Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers. de Cuba EM; Snaebjornsson P; Heideman DA; van Grieken NC; Bosch LJ; Fijneman RJ; Belt E; Bril H; Stockmann HB; Hooijberg E; Punt CJ; Koopman M; Nagtegaal ID; Coupé VH; Carvalho B; Meijer GA Int J Cancer; 2016 Mar; 138(5):1139-45. PubMed ID: 26376292 [TBL] [Abstract][Full Text] [Related]
13. High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort. Sorbye H; Dragomir A; Sundström M; Pfeiffer P; Thunberg U; Bergfors M; Aasebø K; Eide GE; Ponten F; Qvortrup C; Glimelius B PLoS One; 2015; 10(6):e0131046. PubMed ID: 26121270 [TBL] [Abstract][Full Text] [Related]
14. Association of BMI and major molecular pathological markers of colorectal cancer in men and women. Carr PR; Amitay EL; Jansen L; Alwers E; Roth W; Herpel E; Kloor M; Schneider M; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M Am J Clin Nutr; 2020 Mar; 111(3):562-569. PubMed ID: 31897467 [TBL] [Abstract][Full Text] [Related]
15. Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis. Hughes LA; Williamson EJ; van Engeland M; Jenkins MA; Giles GG; Hopper JL; Southey MC; Young JP; Buchanan DD; Walsh MD; van den Brandt PA; Alexandra Goldbohm R; Weijenberg MP; English DR Int J Epidemiol; 2012 Aug; 41(4):1060-72. PubMed ID: 22531127 [TBL] [Abstract][Full Text] [Related]
16. High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases. Fujiyoshi K; Yamamoto G; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K Oncol Rep; 2017 Feb; 37(2):785-792. PubMed ID: 28000889 [TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients. Won DD; Lee JI; Lee IK; Oh ST; Jung ES; Lee SH BMC Cancer; 2017 Jun; 17(1):403. PubMed ID: 28583095 [TBL] [Abstract][Full Text] [Related]
18. Body mass index and molecular subtypes of colorectal cancer. Murphy N; Newton CC; Song M; Papadimitriou N; Hoffmeister M; Phipps AI; Harrison TA; Newcomb PA; Aglago EK; Berndt SI; Brenner H; Buchanan DD; Cao Y; Chan AT; Chen X; Cheng I; Chang-Claude J; Dimou N; Drew D; Farris AB; French AJ; Gallinger S; Georgeson P; Giannakis M; Giles GG; Gruber SB; Harlid S; Hsu L; Huang WY; Jenkins MA; Laskar RS; Le Marchand L; Limburg P; Lin Y; Mandic M; Nowak JA; Obón-Santacana M; Ogino S; Qu C; Sakoda LC; Schoen RE; Southey MC; Stadler ZK; Steinfelder RS; Sun W; Thibodeau SN; Toland AE; Trinh QM; Tsilidis KK; Ugai T; Van Guelpen B; Wang X; Woods MO; Zaidi SH; Gunter MJ; Peters U; Campbell PT J Natl Cancer Inst; 2023 Feb; 115(2):165-173. PubMed ID: 36445035 [TBL] [Abstract][Full Text] [Related]
19. Smoking and risk of colorectal cancer according to KRAS and BRAF mutation status in a Japanese prospective Study. Nakano S; Yamaji T; Shiraishi K; Hidaka A; Shimazu T; Kuchiba A; Saito M; Kunishima F; Nakaza R; Kohno T; Sawada N; Inoue M; Tsugane S; Iwasaki M Carcinogenesis; 2023 Aug; 44(6):476-484. PubMed ID: 37352389 [TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy. Murcia O; Juárez M; Rodríguez-Soler M; Hernández-Illán E; Giner-Calabuig M; Alustiza M; Egoavil C; Castillejo A; Alenda C; Barberá V; Mangas-Sanjuan C; Yuste A; Bujanda L; Clofent J; Andreu M; Castells A; Llor X; Zapater P; Jover R PLoS One; 2018; 13(9):e0203051. PubMed ID: 30188916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]